Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Conversion Study to Optimize Immunosuppressive Regimen by Exchange of Azathioprine by Mycophenolate mofetil and Cyclosporine A Dose Reduction for Patients After Heart Transplantation in Long-Term.

Trial Profile

Conversion Study to Optimize Immunosuppressive Regimen by Exchange of Azathioprine by Mycophenolate mofetil and Cyclosporine A Dose Reduction for Patients After Heart Transplantation in Long-Term.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Ciclosporin; Mycophenolate mofetil
  • Indications Heart transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Sep 2008 Actual patient number (23) added as reported by ClinicalTrials.gov.
    • 08 Sep 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 08 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top